Please try another search
Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. The company was incorporated in 2010 and is based in Oslo, Norway.
Name | Age | Since | Title |
---|---|---|---|
Dmitriy Zamarin | - | 2020 | Member of Medical Advisory Board |
Diane Mary Mellett | 64 | 2015 | Independent Non-Executive Director |
Robert Forbes Burns | 77 | 2015 | Independent Director |
Thomas Falck | 58 | 2022 | Director |
Dean A. Fennell | - | 2020 | Member of Scientific Advisory Board |
Damian Marron | 62 | 2020 | Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review